Nabriva Therapeutics plc (NBRV) Rose 5.58% or 0.14 To Price $2.65 On Tuesday


Nabriva Therapeutics plc (NBRV) rose 5.58% or 0.14 to $2.65. It is approximately 985546 shares traded, which is 84.44% compare to the average total volume 1.17 million. The market cap of NBRV is $184.70 million. The year to date change is 54.98%. The 52 week price range is from $1.12 to $6.05. Price of NBRV have changed -8.06% during last week. It have changed 22.44% over last month, 49.40% over last 3 months, -8.73% over last 6 months and -47.27% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBRV is 2.27. It is -14.34% below current price. The 200-day Moving Averages for NBRV is 2.52. It is -4.91% below current price. The 52-week High is 6.05. It is 128.30% from the current price. The 52-week Low is 1.12. It is -57.74% from current price.

There are some statistics of NBRV. It is has market cap $184.70 million. The share outstanding is 69.70 million. The average volume is 1.17 million. The percent of top 15 Institution holding is 54.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBRV is -155.96%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBRV is -113.59%.


Tags:

Share this post